We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pulnovo Medical reported positive results for its radiofrequency device for pulmonary arterial hypertension (PAH) in a presentation at the Transcatheter Cardiovascular Therapeutics annual scientific symposium in Boston, Mass. Read More
The Regeneten Biodinductive Implant from Britain’s Smith+Nephew delivered an 86 percent reduction in rotator cuff re-tear rates at 12 months, according to interim study results presented at a conference last week in Dublin. Read More
New research published in the NEJM Evidence shows potential for Nordic Bioscience’s PRO-C6 assay becoming a next-generation biomarker in trials studying patients with heart failure with preserved ejection fraction (HFpEF). Read More
All people are not the same. While glaringly obvious, that truth is often ignored in clinical trials. And fixing that problem requires companies to understand and overcome a myriad of barriers, according to a panel discussion held at the annual meeting of the Regulatory Affairs Professionals Society (RAPS) in Phoenix this week. Read More
South Korea’s Lunit INSIGHT CXR artificial intelligence (AI) system improved radiologists’ findings in chest X-rays in four abnormalities, according to study findings published in JAMA Network Open on Aug. 31. Read More
Three-year results continue to show that Abbott’s Amplatzer Piccolo Occluder, which was approved by the FDA in 2019, is safe and effective in nonsurgically closing a hole in the heart of premature infants. Read More
AposHealth’s Apos biomechanical knee treatment helped most patients suffering from disabling osteoarthritis (OA) to be able to delay knee replacement surgery for 24 months, according to data from an observational study published in the journal Population Health Management. Read More
A group of researchers representing devicemakers, academic institutions and the FDA has published a list of factors device developers should consider when collecting patient preference information (PPI) to help design trials. Read More
Medcura’s injectable biopolymer LifeFoam significantly extended survival time in an animal study, researchers reported in the journal Surgery. Read More
Patients with type 1 diabetes using Medtronic’s MiniMed 780G insulin pump system had reduced blood glucose levels and increased time spent in the target blood sugar range compared to patients given insulin injections, researchers reported in the journal The Lancet Diabetes & Endocrinology. Read More
Nearly 60 percent of patients using Abbott’s Heartmate 3 heart pump are reaching the five-year survival mark, according to results of a postmarket study reported at the 2022 European Society of Cardiology Congress in Barcelona, Spain, Aug. 26-29. Read More